Johnson & Johnson Unveils Details On Ottava Soft-Tissue Robot, Chasing Intuitive, Medtronic
J&J said its Ottava robotic platform has six robotic arms, “zero footprint,” and can be used for various procedures.
You may also be interested in...
J&J expects its medical device sales to begin growing rapidly by the middle of 2021 as the pandemic subsides.
New published results demonstrate J&J/Auris’ robotic is safe and effective at diagnosing peripheral pulmonary lesions.
Intuitive reported better-than-expected second-quarter revenues and announced plans to roll out a new extended use program for certain surgical instruments, but remains cautious for the second half amid the COVID-19 pandemic.